Works about HETEROZYGOUS familial hypercholesterolemia


Results: 84
    1
    2

    Monoclonal Anti-PCSK9 Antibodies: Real-World Data.

    Published in:
    Journal of Clinical Medicine, 2024, v. 13, n. 15, p. 4543, doi. 10.3390/jcm13154543
    By:
    • Guidotti, Giulia;
    • Liberati, Viola;
    • Sorrentino, Andrea;
    • Lotti, Elena;
    • Crudele, Felice;
    • Rogolino, Angela;
    • Sammartino, Aniello;
    • Slanzi, Margherita;
    • Gori, Anna Maria;
    • Marcucci, Rossella;
    • Berteotti, Martina
    Publication type:
    Article
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17

    Oral Porphyromonas gingivalis and Fusobacterium nucleatum Abundance in Subjects in Primary and Secondary Cardiovascular Prevention, with or without Heterozygous Familial Hypercholesterolemia.

    Published in:
    Biomedicines, 2022, v. 10, n. 9, p. 2144, doi. 10.3390/biomedicines10092144
    By:
    • Curia, Maria Cristina;
    • Pignatelli, Pamela;
    • D'Antonio, Domenica Lucia;
    • D'Ardes, Damiano;
    • Olmastroni, Elena;
    • Scorpiglione, Luca;
    • Cipollone, Francesco;
    • Catapano, Alberico Luigi;
    • Piattelli, Adriano;
    • Bucci, Marco;
    • Magni, Paolo
    Publication type:
    Article
    18

    Effects of Lipid Lowering Therapy Optimization by PCSK9 Inhibitors on Circulating CD34+ Cells and Pulse Wave Velocity in Familial Hypercholesterolemia Subjects without Atherosclerotic Cardiovascular Disease: Real-World Data from Two Lipid Units.

    Published in:
    Biomedicines, 2022, v. 10, n. 7, p. N.PAG, doi. 10.3390/biomedicines10071715
    By:
    • Scicali, Roberto;
    • Mandraffino, Giuseppe;
    • Scuruchi, Michele;
    • Lo Gullo, Alberto;
    • Di Pino, Antonino;
    • Ferrara, Viviana;
    • Morace, Carmela;
    • Aragona, Caterina Oriana;
    • Squadrito, Giovanni;
    • Purrello, Francesco;
    • Piro, Salvatore
    Publication type:
    Article
    19
    20
    21
    22

    Current causes of death in familial hypercholesterolemia.

    Published in:
    Lipids in Health & Disease, 2022, v. 21, n. 1, p. 1, doi. 10.1186/s12944-022-01671-5
    By:
    • Marco-Benedí, Victoria;
    • Bea, Ana M.;
    • Cenarro, Ana;
    • Jarauta, Estíbaliz;
    • Laclaustra, Martín;
    • Civeira, Fernando
    Publication type:
    Article
    23
    24
    25
    26

    Echocardiographic Calcium Score of Aortic Valve Correlates with Coronary Artery Calcium Score in Heterozygous Familial Hypercholesterolemia.

    Published in:
    Life (2075-1729), 2025, v. 15, n. 3, p. 506, doi. 10.3390/life15030506
    By:
    • Cefalù, Angelo Baldassare;
    • Nardi, Emilio;
    • Giammanco, Antonina;
    • Gagliardo, Carola Maria;
    • Barbagallo, Carlo Maria;
    • La Grutta, Ludovico;
    • Toia, Patrizia;
    • Brucato, Federica;
    • Scrimali, Chiara;
    • Fasciana, Teresa Maria Grazia;
    • Spina, Rossella;
    • Lanza, Marina;
    • Vitale, Francesco;
    • Noto, Davide;
    • Averna, Maurizio
    Publication type:
    Article
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39

    A Comprehensive Review of PCSK9 Inhibitors.

    Published in:
    Journal of Cardiovascular Pharmacology & Therapeutics, 2022, v. 27, p. 1, doi. 10.1177/10742484221100107
    By:
    • Coppinger, Caroline;
    • Movahed, Mohammad Reza;
    • Azemawah, Veronica;
    • Peyton, Lee;
    • Gregory, James;
    • Hashemzadeh, Mehrnoosh
    Publication type:
    Article
    40
    41
    42
    43
    44

    PCSK9 Plasma Levels Are Associated with Mechanical Vascular Impairment in Familial Hypercholesterolemia Subjects without a History of Atherosclerotic Cardiovascular Disease: Results of Six-Month Add-On PCSK9 Inhibitor Therapy.

    Published in:
    Biomolecules (2218-273X), 2022, v. 12, n. 4, p. 562, doi. 10.3390/biom12040562
    By:
    • Toscano, Arianna;
    • Cinquegrani, Maria;
    • Scuruchi, Michele;
    • Di Pino, Antonino;
    • Piro, Salvatore;
    • Ferrara, Viviana;
    • Morace, Carmela;
    • Lo Gullo, Alberto;
    • Imbalzano, Egidio;
    • Purrello, Francesco;
    • Squadrito, Giovanni;
    • Scicali, Roberto;
    • Mandraffino, Giuseppe
    Publication type:
    Article
    45
    46
    47
    48
    49
    50

    Multimodal lipid-lowering treatment in pediatric patients with homozygous familial hypercholesterolemia—target attainment requires further increase of intensity.

    Published in:
    Pediatric Nephrology, 2018, v. 33, n. 7, p. 1199, doi. 10.1007/s00467-018-3906-6
    By:
    • Klaus, Günter;
    • Taylan, Christina;
    • Büscher, Rainer;
    • Schmitt, Claus Peter;
    • Pape, Lars;
    • Oh, Jun;
    • Driemeyer, Joenna;
    • Galiano, Matthias;
    • König, Jens;
    • Schürfeld, Carsten;
    • Spitthöver, Ralf;
    • Schaefer, Juergen R.;
    • Weber, Lutz T.;
    • Heibges, Andreas;
    • Klingel, Reinhard
    Publication type:
    Article